NUIVIUM
DEAD

Serial Number

97552355

Owner

Triviumvet DAC

Attorney

Sean P. McMahon

Filing Date

Aug 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NUIVIUM Trademark

Serial Number: 97552355

NUIVIUM is a trademark filed by Triviumvet DAC on August 17, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Triviumvet DAC (9 trademarks)

Unit 3A Cleaboy Business Park
Waterford X91H5FE , IE

Entity Type: 99

Trademark Details

Filing Date

August 17, 2022

Registration Date

Not Registered

Goods & Services

veterinary preparations, namely, gastroprotectants, pain relief medication, diagnostic preparations for veterinary use and purposes and veterinary preparations for companion animals for the treatment of age related diseases; veterinary preparations for companion animals for the treatment and prevention of cardiac disorders and age related illnesses; veterinary substances, namely, immunosuppressants for veterinary use and animal appropriate preparations for veterinary use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations for veterinary use for the treatment and prevention of cardiac disorders and age related illnesses; chemical preparations for veterinary use, namely, chemical preparations for the diagnosis and treatment of cardiac disorders and age related illnesses in companion animals; medicines for veterinary purposes for the treatment of cardiac disorders and age related illnesses; veterinary vaccines; pharmaceutical preparations, medicines and drugs for the diagnosis and treatment of dental diseases and disorders, metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system

research and development services in the field of cardiac disorders and age related illnesses; scientific research services; research into new products for animals; product testing; product safety and quality testing; research and testing services in the field of veterinary drugs; pharmaceutical research services, namely, assessing the efficacy of human drugs for animals; pharmaceutical research services, namely, assessing the efficacy of veterinary drugs; provision of information and data relating to veterinary research and product development; consultancy relating to research and product development in the field of animal therapeutics; research into new products for humans; research, development and testing services in the field of pharmaceutical preparations, medicines and drugs; pharmaceutical product evaluation; pharmaceutical research services; conducting clinical trials for pharmaceutical products, medicines and drugs for others; provision of information and data relating to pharmaceutical research and development and clinical trials

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Nov 7, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Nov 7, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Nov 7, 2023 ABN2
ASSIGNED TO EXAMINER
Nov 6, 2023 DOCK
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 8, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 8, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 8, 2023 CNRT
ASSIGNED TO EXAMINER
Jun 5, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 7, 2022 NWOS
NEW APPLICATION ENTERED
Aug 20, 2022 NWAP